Association between Quality of Life and Visual Acuity in a Randomized Clinical Trial of Patients with Uveitis Taking Antimetabolites

References

• Durrani OM, Meads CA, Murray PI. Uveitis: a potentially blinding disease. Ophthalmologica. 2004;218(4):223–236. doi:10.1159/000078612.
   PubMed Web of Science ®Google Scholar
• Thorne JE, Skup M, Tundia N, et al. Direct and indirect resource use, healthcare costs and work force absence in patients with non-infectious intermediate, posterior or panuveitis. Acta Ophthalmol. 2016;94(5):e331–e339. doi:10.1111/aos.12987.
   PubMed Web of Science ®Google Scholar
• Frick KD, Drye LT, Kempen JH, et al. Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial. Invest Ophthalmol Vis Sci. 2012;53(3):1169–1176. doi:10.1167/iovs.11-8259.
   PubMed Web of Science ®Google Scholar
• Pasadhika S, Rosenbaum JT. Update on the use of systemic biologic agents in the treatment of noninfectious uveitis. Biologics. 2014;8:67–81. doi:10.2147/BTT.S41477.
   PubMedGoogle Scholar
• Mangione CM. Development of the 25-list-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119(7):1050. doi:10.1001/archopht.119.7.1050.
   PubMed Web of Science ®Google Scholar
• Brown MM, Brown GC, Sharma S, Busbee B. Quality of life associated with visual loss: a time tradeoff utility analysis comparison with medical health states. Ophthalmology. 2003;110(6):1076–1081. doi:10.1016/S0161-6420(03)00254-9.
   PubMed Web of Science ®Google Scholar
• Dong LM. Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4. Am J Ophthalmol. 2004;138(1):91–108. doi:10.1016/j.ajo.2004.02.011.
   PubMed Web of Science ®Google Scholar
• Murphy CC, Greiner K, Plskova J, Frost NA, Forrester JV, Dick AD. Validity of using vision-related quality of life as a treatment end point in intermediate and posterior uveitis. British J Ophthalmol. 2007;91(2):154–156. doi:10.1136/bjo.2006.105528.
   PubMed Web of Science ®Google Scholar
• Venkataraman A, Rathinam S. A pre- and post-treatment evaluation of vision-related quality of life in uveitis. Indian J Ophthalmol. 2008;56(4):307. doi:10.4103/0301-4738.39662.
   PubMed Web of Science ®Google Scholar
• Kempen JH, Jabs DA. Quality of life and risks associated with systemic anti-inflammatory therapy versus fluocinolone acetonide intraocular implant for intermediate uveitis, posterior uveitis, or panuveitis: fifty-four-month results of the Multicenter Uveitis Steroid Treatment Trial and Follow-up Study. Ophthalmology. 2015;122(10):1976–1986. doi:10.1016/j.ophtha.2015.06.043.
   PubMed Web of Science ®Google Scholar
• Schiffman RM, Jacobsen G, Whitcup SM. Visual Functioning and General Health Status in Patients with Uveitis. Arch Ophthalmol. 2001:119:841–849. PMID: 11405835.
   Google Scholar
• Miserocchi E, Modorati G, Mosconi P, Colucci A, Bandello F. Quality of life in patients with uveitis on chronic systemic immunosuppressive treatment. Ocul Immunol Inflamm. 2010;18(4):297–304. doi:10.3109/09273941003637510.
   PubMed Web of Science ®Google Scholar
• Jalil A, Yin K, Coyle L, Harper R, Jones NP. Vision-related quality of life and employment status in patients with uveitis of working age: a prospective study. Ocul Immunol Inflamm. 2012;20(4):262–265. doi:10.3109/09273948.2012.684420.
   PubMed Web of Science ®Google Scholar
• Kaleemunnisha S, Sudharshan S, Biswas J. Quality of life in non-infectious uveitis patients on immunosuppressive therapy. Middle East Afr J Ophthalmol. 2014;21(3):225–231. doi:10.4103/0974-9233.134675.
   PubMedGoogle Scholar
• Rathinam SR, Gonzales JA, Thundikandy R, et al. Effect of corticosteroid-sparing treatment with Mycophenolate Mofetil vs Methotrexate on inflammation in patients with uveitis: a randomized clinical trial. JAMA. 2019;322(10):936–945. doi:10.1001/jama.2019.12618.
   PubMed Web of Science ®Google Scholar
• Kelly NK, Chattopadhyay A, Rathinam SR, et al. Health- and vision-related quality of life in a randomized controlled trial comparing methotrexate and mycophenolate mofetil for uveitis. Ophthalmology. Published online 2021;128(9):1337–1345. doi:10.1016/j.ophtha.2021.02.024.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Rosenbaum JT, Foster CS, et al. PERSPECTIVE Guidelines for the Use of Immunosuppressive Drugs in Patients with Ocular Inflammatory Disorders: Recommendations of an Expert Panel. Am J Ophthalmol. 2000;1:492–513. PMID: 11024423.
   Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT, Group S of UN (SUN) W. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509–516. doi:10.1016/j.ajo.2005.03.057.
   PubMed Web of Science ®Google Scholar
• Gupta SK, Viswanath K, Thulasiraj RD, et al. The development of the Indian vision function questionnaire: field testing and psychometric evaluation. British J Ophthalmol. 2005;89(5):621–627. doi:10.1136/bjo.2004.050732.
   PubMed Web of Science ®Google Scholar
• Seddon J, Fong D, Massof RW, Rubin GS. PUBLIC HEALTH AND THE EYE Visual Function Assessment Questionnaires. Surv Ophthalmol. 2001;45:531–548.
   Google Scholar
• Sheppard J, Joshi A, Betts KA, et al. Effect of Adalimumab on visual functioning in patients with noninfectious intermediate uveitis, posterior uveitis, and panuveitis in the VISUAL-1 and VISUAL-2 trials. JAMA Ophthalmol. 2017;135(6):511–518. doi:10.1001/jamaophthalmol.2017.0603.
   PubMed Web of Science ®Google Scholar
• Sugar EA, Burke AE, Venugopal V, Thorne JE, Holbrook JT. Responsiveness of vision-specific and general quality of life metrics to ocular and systemic events in patients with uveitis. Ophthalmology. 2020;127(12):1710–1718. doi:10.1016/j.ophtha.2020.07.038.
   PubMed Web of Science ®Google Scholar
• Schippert AC, Jelin E, Moe MC, Heiberg T, Grov EK. The impact of age-related macular degeneration on quality of life and its association with demographic data: results from the NEI VFQ-25 questionnaire in a Norwegian population. Gerontol Geriatr Med. 2018;4:233372141880160. doi:10.1177/2333721418801601.
   Web of Science ®Google Scholar
• Finger RP, Kupitz DG, Holz FG, et al. The impact of the severity of vision loss on vision-related quality of life in India: an evaluation of the IND-VFQ-33. Invest Ophthalmol Vis Sci. 2011;52(9):6081–6088. doi:10.1167/iovs.11-7388.
   PubMed Web of Science ®Google Scholar
• Ware JSC. The MOS 36-Item Short-Form Health Survey (SF-36): conceptual framework and item selection. Med Care. 1992;30(6). doi:10.1097/00005650-199206000-00002.
   Web of Science ®Google Scholar
• Brazier JE, Harper R, Jones NM, Thomas KJ, Usherwood T, Westlake L. GENERAL PRACTICE Validating the SF-36 Health Survey Questionnaire: New Outcome Measure for Primary Care. BMJ. 1992;305:160–164. PMID: 1285753.
   Google Scholar
• Maruish M, DeRosa M. A guide to the integration of certified Short Form survey scoring and data quality evaluation capabilities. Published online 2009.
   Google Scholar
• Tarlov AR, Ware JE Jr, Greenfield S, Nelson EC, Perrin E, Zubkoff M. The Medical Outcomes Study: an application of methods for monitoring the results of medical care. JAMA. 1989;262(7):925–930. doi:10.1001/jama.1989.03430070073033.
   PubMed Web of Science ®Google Scholar
• Aarthy R, Mikocka-Walus A, Pradeepa R, Anjana RM, Mohan V, Aston-Mourney K. Quality of life and diabetes in India: a scoping review. Indian J Endocrinol Metab. 2021;25(5):365–380. doi:10.4103/ijem.ijem_336_21.
   PubMedGoogle Scholar
• Janani K, Jain M, Vargese J, et al. Health-related quality of life in liver cirrhosis patients using SF-36 and CLDQ questionnaires. Clin Exp Hepatol. 2018;4(4):232–239. doi:10.5114/ceh.2018.80124.
   PubMed Web of Science ®Google Scholar
• Varma GR, Yadlapalli K, Babu B. Health-related quality of life of elderly living in the rural community and homes for the elderly in a district of India: application of the short form 36 (SF-36) health survey questionnaire. Z Gerontol Geriatr. 2009;43:259–263. doi:10.1007/s00391-009-0077-x.
   PubMed Web of Science ®Google Scholar
• Sinha R, van den Heuvel WJA, Arokiasamy P. Validity and reliability of MOS Short Form Health Survey (SF-36) for use in India. Indian J Community Med. 2013;38(1):22–26. doi:10.4103/0970-0218.106623.
   PubMedGoogle Scholar
• The Age-Related Eye Disease Study (AREDS): Design Implications AREDS Report No. 1; 2006.
   Google Scholar
• Walters SJ, Brazier JE. What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health Qual Life Outcomes. 2003;1:4. doi:10.1186/1477-7525-1-4.
   PubMedGoogle Scholar
• Suñer IJ, Kokame GT, Yu E, Ward J, Dolan C, Bressler NM. Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials. Invest Ophthalmol Vis Sci. 2009;50(8):3629–3635. doi:10.1167/iovs.08-3225.
   PubMed Web of Science ®Google Scholar
• Finger RP, Kupitz DG, Fenwick E, et al. The impact of successful cataract surgery on quality of life, household income and social status in South India. PLoS One. 2012;7(8):e44268. doi:10.1371/journal.pone.0044268.
   PubMed Web of Science ®Google Scholar
• Niemeyer KM, Gonzales JA, Rathinam SR, et al. Quality-of-life outcomes from a randomized clinical trial comparing antimetabolites for intermediate, posterior, and panuveitis. Am J Ophthalmol. 2017;179:10–17. doi:10.1016/j.ajo.2017.04.003.
   PubMed Web of Science ®Google Scholar